Order Article Reprints

Schumacher D, Curaj A, Staudt M, Cordes F, Dumitraşcu AR, Rolles B, Beckers C, Soppert J, Rusu M, Simsekyilmaz S, et al. Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. International Journal of Molecular Sciences. 2021; 22(9):4401. https://doi.org/10.3390/ijms22094401

Schumacher, David, Adelina Curaj, Mareike Staudt, Franziska Cordes, Andreea R. Dumitraşcu, Benjamin Rolles, Christian Beckers, Josefin Soppert, Mihaela Rusu, Sakine Simsekyilmaz, and et al. 2021. "Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling" International Journal of Molecular Sciences 22, no. 9: 4401. https://doi.org/10.3390/ijms22094401

Schumacher, D., Curaj, A., Staudt, M., Cordes, F., Dumitraşcu, A. R., Rolles, B., Beckers, C., Soppert, J., Rusu, M., Simsekyilmaz, S., Kneizeh, K., Ramachandra, C. J. A., Hausenloy, D. J., & Liehn, E. A. (2021). Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. International Journal of Molecular Sciences, 22(9), 4401. https://doi.org/10.3390/ijms22094401